{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:58:31Z","timestamp":1792180711231,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-08716-x","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T08:34:07Z","timestamp":1736325247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A single-centre randomised controlled trial comparing the standard method and target-controlled infusion as a method of administering cefoxitin, which is used to prevent surgical site infections in colorectal surgical patients: study protocol"],"prefix":"10.1186","volume":"26","author":[{"given":"Ha-Jung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Mi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Lyul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ja","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6561-8851","authenticated-orcid":false,"given":"Byung-Moon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"8716_CR1","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","volume":"152","author":"SI Berrios-Torres","year":"2017","unstructured":"Berrios-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152:784\u201391.","journal-title":"JAMA Surg"},{"key":"8716_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/sur.2013.9999","volume":"14","author":"DW Bratzler","year":"2013","unstructured":"Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013;14:73\u2013156.","journal-title":"Surg Infect (Larchmt)"},{"key":"8716_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/DCR.0000000000000633","volume":"59","author":"J Poeran","year":"2016","unstructured":"Poeran J, Wasserman I, Zubizarreta N, Mazumdar M. Characteristics of antibiotic prophylaxis and risk of surgical site infections in open colectomies. Dis Colon Rectum. 2016;59:733\u201342.","journal-title":"Dis Colon Rectum"},{"key":"8716_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0196-6553(99)70088-X","volume":"27","author":"AJ Mangram","year":"1999","unstructured":"Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27:97\u2013132 quiz 133-134; discussion 196.","journal-title":"Am J Infect Control"},{"key":"8716_CR5","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1111\/bcp.14883","volume":"87","author":"KM Kim","year":"2021","unstructured":"Kim KM, Kim SH, Yun HY, et al. Development of a new pharmacokinetic model for target-concentration controlled infusion of cefoxitin as a prophylactic antibiotic in colorectal surgical patients. Br J Clin Pharmacol. 2021;87:4648\u201357.","journal-title":"Br J Clin Pharmacol"},{"key":"8716_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.phrs.2018.07.005","volume":"134","author":"F de Velde","year":"2018","unstructured":"de Velde F, Mouton JW, de Winter BCM, van Gelder T, Koch BCP. Clinical applications of population pharmacokinetic models of antibiotics: challenges and perspectives. Pharmacol Res. 2018;134:280\u20138.","journal-title":"Pharmacol Res"},{"key":"8716_CR7","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/bja\/aex026","volume":"118","author":"BI Naik","year":"2017","unstructured":"Naik BI, Roger C, Ikeda K, et al. Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trial. Br J Anaesth. 2017;118:876\u201382.","journal-title":"Br J Anaesth"},{"key":"8716_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1213\/ANE.0000000000001009","volume":"122","author":"AR Absalom","year":"2016","unstructured":"Absalom AR, Glen JI, Zwart GJ, Schnider TW, Struys MM. Target-controlled infusion: a mature technology. Anesth Analg. 2016;122:70\u20138.","journal-title":"Anesth Analg"},{"key":"8716_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1213\/ANE.0000000000001008","volume":"122","author":"MM Struys","year":"2016","unstructured":"Struys MM, De Smet T, Glen JI, Vereecke HE, Absalom AR, Schnider TW. The history of target-controlled infusion. Anesth Analg. 2016;122:56\u201369.","journal-title":"Anesth Analg"},{"key":"8716_CR10","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"key":"8716_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/anae.14327","volume":"73","author":"BM Choi","year":"2018","unstructured":"Choi BM, Park C, Lee YH, et al. Development of a new analgesic index using nasal photoplethysmography. Anaesthesia. 2018;73:1123\u201330.","journal-title":"Anaesthesia"},{"key":"8716_CR12","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/1440-1681.13695","volume":"49","author":"HU Kang","year":"2022","unstructured":"Kang HU, Kim KM, Choi JM, et al. Predictive performance of pharmacokinetic models for target concentration-controlled infusion of cefoxitin as a prophylactic antibiotic in patients with colorectal surgery. Clin Exp Pharmacol Physiol. 2022;49:1126\u201335.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"8716_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1086\/646436","volume":"13","author":"TC Horan","year":"1992","unstructured":"Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606\u20138.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8716_CR14","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179-184.","journal-title":"Nephron Clin Pract"},{"key":"8716_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1213\/ANE.0000000000001005","volume":"122","author":"TW Schnider","year":"2016","unstructured":"Schnider TW, Minto CF, Struys MM, Absalom AR. The safety of target-controlled infusions. Anesth Analg. 2016;122:79\u201385.","journal-title":"Anesth Analg"},{"key":"8716_CR16","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/bcp.15943","volume":"90","author":"SH Lee","year":"2024","unstructured":"Lee SH, Yoon H, Park J, et al. External validation of a pharmacokinetic model for target-controlled infusion of cefazolin as a prophylactic antibiotic. Br J Clin Pharmacol. 2024;90:582\u20137.","journal-title":"Br J Clin Pharmacol"},{"key":"8716_CR17","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1093\/jac\/dkz139","volume":"74","author":"M Boisson","year":"2019","unstructured":"Boisson M, Torres BGS, Yani S, et al. Reassessing the dosing of cefoxitin prophylaxis during major abdominal surgery: insights from microdialysis and population pharmacokinetic modelling. J Antimicrob Chemother. 2019;74:1975\u201383.","journal-title":"J Antimicrob Chemother"},{"key":"8716_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2146\/ajhp120568","volume":"70","author":"DW Bratzler","year":"2013","unstructured":"Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195\u2013283.","journal-title":"Am J Health Syst Pharm"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08716-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08716-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T21:29:31Z","timestamp":1736371771000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08716-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8716"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08716-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Asan Medical Center (approval number: 2022\u20130180, approval date: February 12, 2022). This study was registered on an international clinical trials registry platform (, principal investigator: Byung-Moon Choi, registration date: February 23, 2022). With this study protocol, the Ministry of Food and Drug Safety of Korea approved the clinical trial (approval number: 101076, protocol number: 202200837). Written informed consent was obtained from one of the parents of each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable. No identifying images or other personal or clinical details of the participants are presented here or will be presented in reports of the trial results. Informed consent materials are available from the corresponding author upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"11"}}